FABP5 and squamous cell lung carcinoma: Additionally, the results of disease-free survival (DFS) analysis showed that high FABP5 expression was statistically associated with poor prognosis in ACC, BRCA, KIRC, LGG, LUAD and UVM, but favorable prognosis in lung squamous cell carcinoma (LUSC) (ACC p = 0.012, BRCA p = 0.022, KIRC p = 0.024, LGG p = 0.003, LUAD p = 0.038, LUSC p = 0.045, UVM p = 0.007, Fig. 2B).